Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia最新文献_第7页

Temporary Stenting for Anastomotic Stenosis after Tracheal Resection of Adenoid Cystic Carcinoma: A Case Report. 腺样囊性癌气管切除术后吻合口狭窄的临时支架治疗：一例报告。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2023-10-20 Epub Date: 2022-03-25 DOI: 10.5761/atcs.cr.22-00009

Ryosuke Amemiya, Ikki Takada, Taisuke Matsubara, Shotaro Ono, Yukio Morishita, Norihiko Ikeda, Kinya Furukawa

引用次数: 0

Two Cases of Surgical Correction of Recurrent Mitral Regurgitation due to Failed Catheter- Delivered Mitral Clip (MitraClip). 两例因导管输送的二尖瓣夹（MitraClip）失败而复发的二尖瓣反流的手术矫正。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2023-10-20 Epub Date: 2022-03-26 DOI: 10.5761/atcs.cr.22-00002

Masahide Komagamine, Kan Nawata, Shota Kita, Kiyoshi Chiba, Shingo Kuwata, Yoshihiro Akashi, Takeshi Miyairi

{"title":"Two Cases of Surgical Correction of Recurrent Mitral Regurgitation due to Failed Catheter- Delivered Mitral Clip (MitraClip).","authors":"Masahide Komagamine, Kan Nawata, Shota Kita, Kiyoshi Chiba, Shingo Kuwata, Yoshihiro Akashi, Takeshi Miyairi","doi":"10.5761/atcs.cr.22-00002","DOIUrl":"10.5761/atcs.cr.22-00002","url":null,"abstract":"<p><p>From April 2018 to February 2021, 150 patients underwent MitraClip implantation for severe functional mitral regurgitation (MR) at our hospital. Two of our patients, an 85-year-old man and an 84-year-old woman, developed a single leaflet device attachment in the acute phase after the implantation and had severe residual MR requiring surgical correction. The recurrent MR was first pointed out on day 5 and day 4, and the duration between MitraClip implantation and surgery was 13 and 55 days, respectively. Due to strong adhesions with the clips and severe valve damage after MitraClip implantation, both cases underwent mitral valve replacement with a good postoperative course. In patients with a high-risk baseline profile, surgical mitral valve replacement after failed MitraClip implantation should be considered at an optimal timing, and a detailed echocardiographic follow-up is required.</p>","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":" ","pages":"266-269"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/2b/atcs-29-266.PMC10587475.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49686209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erratum. 勘误表。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2019-01-01 DOI: 10.5761/atcs.err.19-01000

引用次数: 0

Late-Onset Pulmonary Fistula after Resection of Pulmonary Metastasis from Colorectal Cancer Following Perioperative Chemotherapy with Bevacizumab. 贝伐单抗围手术期化疗后结直肠癌肺转移切除后的晚发性肺瘘。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-06-20 DOI: 10.5761/atcs.cr.16-00117

R. Kanzaki, Y. Shintani, M. Inoue, T. Kawamura, S. Funaki, M. Minami, M. Okumura

引用次数: 4

Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement. 主动脉瓣置换术后2年三瓣生物假体的纯粹尖端撕裂。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-06-20 DOI: 10.5761/atcs.cr.16-00183

M. Hamamoto, Taira Kobayashi, Masamichi Ozawa, Kosuke Yoshimura

引用次数: 23

Solitary Fibrous Tumor - Less Common Neoplasms of the Pleural Cavity. 孤立性纤维性肿瘤-胸膜腔少见的肿瘤。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-02-20 DOI: 10.5761/atcs.oa.16-00108

Š. Vejvodová, V. Špidlen, P. Mukeňsnabl, G. Krákorová, J. Molacek, J. Vodička

{"title":"Solitary Fibrous Tumor - Less Common Neoplasms of the Pleural Cavity.","authors":"Š. Vejvodová, V. Špidlen, P. Mukeňsnabl, G. Krákorová, J. Molacek, J. Vodička","doi":"10.5761/atcs.oa.16-00108","DOIUrl":"https://doi.org/10.5761/atcs.oa.16-00108","url":null,"abstract":"PURPOSE\u0000solitary fibrous tumors (SFT) represent a heterogeneous group of primary pleural neoplasms with a low incidence rate and of which the biological origin, which consists of mesenchymal cells, is uncertain.\u0000\u0000\u0000METHODS\u0000The authors present herewith a retrospective analysis of 22 patients with SFTs who were diagnosed and surgically treated between the years 2000-2015. The preoperative tumors were successfully verified morphologically by transthoracic core needle biopsy under CT control in 27.3% of patients. Surgical approaches were either posterolateral thoracotomy or videothoracoscopy. The follow-up median was 45 months (range 1-188 months).\u0000\u0000\u0000RESULTS\u0000Twenty tumors were surgically removed radically, two tumors were found to be unresectable due to the considerable tumor size. From histological point of view 81.8% of tumors were SFT with low malignant potential, 18.2% of tumors with high malignant potential. Despite the radical extirpation of the SFT, it relapsed in two patients.\u0000\u0000\u0000CONCLUSION\u0000The gold standard of SFT treatment is radical surgical removal; however, patients at risk of recurrence require additional follow-ups. The results of adjuvant therapy in recurrent and malignant forms of SFTs are the subject of discussion and further study.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"1 1","pages":"12-18"},"PeriodicalIF":0.0,"publicationDate":"2017-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90576118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung. 铂基辅助化疗治疗II期和III期肺鳞状细胞癌。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-02-20 DOI: 10.5761/atcs.oa.16-00164

T. Isaka, H. Nakayama, T. Yokose, H. Ito, K. Katayama, Kouzo Yamada, M. Masuda

{"title":"Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.","authors":"T. Isaka, H. Nakayama, T. Yokose, H. Ito, K. Katayama, Kouzo Yamada, M. Masuda","doi":"10.5761/atcs.oa.16-00164","DOIUrl":"https://doi.org/10.5761/atcs.oa.16-00164","url":null,"abstract":"INTRODUCTION\u0000The efficacy of platinum-based adjuvant chemotherapy (PBAC) for pathological stage II and stage III squamous cell carcinoma (SCC) of the lung was analyzed retrospectively.\u0000\u0000\u0000MATERIALS AND METHODS\u0000The prognoses of 94 patients with stage II and stage III SCC with or without PBAC (more than three courses of cisplatin-, carboplatin-, and nedaplatin-based adjuvant chemotherapy) were compared.\u0000\u0000\u0000RESULTS\u0000The mean observation period was 46.1 months. PBAC was not administered for the following reasons: 39 (55.7%) patients had comorbidities, 25 (35.7%) were older than 75 years, 19 (27.1%) patients underwent surgery before the approval of PBAC, and 3 (4.3%) patients could not continue PBAC (≤2 cycles) because of adverse events. PBAC patients (n = 24) were significantly younger than non-PBAC patients (n = 70; 66.3 vs 69.6 years old, respectively; p = 0.043). Disease-free survival (DFS) did not differ between PBAC and non-PBAC patients (55.0% and 67.1%, respectively; p = 0.266). PBAC patients tended to have worse overall survival (OS) than non-PBAC patients (56.1% and 70.2%, respectively; p = 0.138). PBAC was not prognostic for OS (hazard ratio (HR), 2.11; 95% confidence interval (CI), 0.82%-5.40%; p = 0.120).\u0000\u0000\u0000CONCLUSION\u0000PBAC did not improve the prognoses of patients with pathological stage II or stage III SCC in the single institution experience.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"28 1","pages":"19-25"},"PeriodicalIF":0.0,"publicationDate":"2017-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75043784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Current Status and Future Prospects for Esophageal Cancer Treatment. 食管癌治疗的现状与展望

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-02-20 DOI: 10.5761/atcs.ra.16-00162

M. Sohda, H. Kuwano

{"title":"Current Status and Future Prospects for Esophageal Cancer Treatment.","authors":"M. Sohda, H. Kuwano","doi":"10.5761/atcs.ra.16-00162","DOIUrl":"https://doi.org/10.5761/atcs.ra.16-00162","url":null,"abstract":"The local control effect of esophagectomy with three-field lymph node dissection (3FLD) is reaching its limit pending technical advancement. Minimally invasive esophagectomy (MIE) by thoracotomy is slowly gaining acceptance due to advantages in short-term outcomes. Although the evidence is slowly increasing, MIE is still controversial. Also, the results of treatment by surgery alone are limiting, and multimodality therapy, which includes surgical and non-surgical treatment options including chemotherapy, radiotherapy, and endoscopic treatment, has become the mainstream therapy. Esophagectomy after neoadjuvant chemotherapy (NAC) is the standard treatment for clinical stages II/III (except for T4) esophageal cancer, whereas chemoradiotherapy (CRT) is regarded as the standard treatment for patients who wish to preserve their esophagus, those who refuse surgery, and those with inoperable disease. CRT is also usually selected for clinical stage IV esophageal cancer. On the other hand, with the spread of CRT, salvage esophagectomy has traditionally been recognized as a feasible option; however, many clinicians oppose the use of surgery due to the associated unfavorable morbidity and mortality profile. In the future, the improvement of each treatment result and the establishment of individual strategies are important although esophageal cancer has many treatment options.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"57 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2017-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78736329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 161

Conduits Used in Coronary Artery Bypass Grafting: A Review of Morphological Studies. 冠状动脉旁路移植术中导管的形态学研究综述。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-02-14 DOI: 10.5761/atcs.ra.16-00178

B. Martínez-González, C. G. Reyes-Hernández, A. Quiroga-Garza, Víctor E Rodríguez-Rodríguez, C. N. Esparza-Hernández, R. Elizondo-Omaña, S. Guzmán-López

{"title":"Conduits Used in Coronary Artery Bypass Grafting: A Review of Morphological Studies.","authors":"B. Martínez-González, C. G. Reyes-Hernández, A. Quiroga-Garza, Víctor E Rodríguez-Rodríguez, C. N. Esparza-Hernández, R. Elizondo-Omaña, S. Guzmán-López","doi":"10.5761/atcs.ra.16-00178","DOIUrl":"https://doi.org/10.5761/atcs.ra.16-00178","url":null,"abstract":"There is a significant variety of vascular conduits options for coronary bypass surgery. Adequate graft selection is the most important factor for the success of the intervention. To ensure durability, permeability, and bypass function, there must be a morphological similarity between the graft and the coronary artery. The objective of this review was to analyze the morphological characteristics of the grafts that are most commonly used in coronary bypass surgery and the coronary arteries that are most frequently occluded. We included clinical information regarding the characteristics that determine the behavior of the grafts and its permeability over time. Currently, the internal thoracic artery is the standard choice for bypass surgery because of the morphological characteristics of the wall that makes less prone to developing atherosclerosis and hyperplasia. The radial and right gastroepiploic arteries are the following second and third best options, respectively. The ulnar artery is the preferred choice when other conduits are not feasible.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"158 1","pages":"55-65"},"PeriodicalIF":0.0,"publicationDate":"2017-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80139952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 70

The Effects of Different BMI on Blood Loss and Transfusions in Chinese Patients Undergoing Coronary Artery Bypass Grafting. 不同BMI对中国冠状动脉搭桥术患者失血和输血的影响。

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia Pub Date : 2017-02-08 DOI: 10.5761/atcs.oa.16-00219

Mingya Wang, Ming Chen, Hushan Ao, Sipeng Chen, Zhifa Wang

{"title":"The Effects of Different BMI on Blood Loss and Transfusions in Chinese Patients Undergoing Coronary Artery Bypass Grafting.","authors":"Mingya Wang, Ming Chen, Hushan Ao, Sipeng Chen, Zhifa Wang","doi":"10.5761/atcs.oa.16-00219","DOIUrl":"https://doi.org/10.5761/atcs.oa.16-00219","url":null,"abstract":"OBJECTIVE\u0000Blood loss is a predictor of outcomes after coronary artery bypass grafting (CABG). This study investigated the effects of body mass index (BMI) on blood loss, blood transfusion rate, and the variations in coagulation parameters of Chinese patients undergoing CABG.\u0000\u0000\u0000METHODS\u0000A total of 1007 Chinese patients who consecutively underwent isolated, primary CABG at Fuwai Hospital from January 1, 2013 to December 31, 2013 were included in this study. They were categorized by BMI into <24 kg/m2 (low and normal weight group), 24≤ BMI <28 kg/m2 (overweight group), and BMI ≥28 kg/m2 (obese group). Following this BMI classification, the quantities of blood lost and recorded transfusions were analyzed.\u0000\u0000\u0000RESULTS\u0000Blood loss and transfusion rates were significantly higher in the low and normal weight group compared with the obese group (p <0.01). Chest tube drainage over 24 h, duration of intensive care unit (ICU) stay, and postoperative mechanical ventilation were higher as well (p <0.01). Atrial fibrillation was closely related to blood transfusion (p <0.001).\u0000\u0000\u0000CONCLUSIONS\u0000Obesity is a predictor for protection against blood loss and transfusion in Chinese people. Patients with low and normal BMI lost more blood per kg of their weight and had higher total transfused volume during isolated primary CABG. Atrial fibrillation was associated with high blood transfusion.","PeriodicalId":93877,"journal":{"name":"Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia","volume":"59 1","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"2017-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84962173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 27